Cargando…

Withaferin-A Treatment Alleviates TAR DNA-Binding Protein-43 Pathology and Improves Cognitive Function in a Mouse Model of FTLD

Withaferin-A, an active withanolide derived from the medicinal herbal plant Withania somnifera induces autophagy, reduces TDP-43 proteinopathy, and improves cognitive function in transgenic mice expressing mutant TDP-43 modelling FTLD. TDP-43 is a nuclear DNA/RNA-binding protein with cellular functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Sunny, Phaneuf, Daniel, Julien, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116414/ https://www.ncbi.nlm.nih.gov/pubmed/33078279 http://dx.doi.org/10.1007/s13311-020-00952-0

Ejemplares similares

Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases
por: Isaacs, A M, et al.
Publicado: (2008)

Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD
por: Kumar, Sunny, et al.
Publicado: (2021)

Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons
por: Pozzi, Silvia, et al.
Publicado: (2020)

Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue
por: Liu-Yesucevitz, Liqun, et al.
Publicado: (2010)

Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration
por: Dutta, Kallol, et al.
Publicado: (2016)

Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivo()
por: Tripathi, Vineeta Bhasker, et al.
Publicado: (2014)

The pathogenic mechanism of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis
por: Wang, Xinxin, et al.
Publicado: (2023)

Correction: Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue
por: Liu-Yesucevitz, Liqun, et al.
Publicado: (2011)

Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS In vitro
por: Wobst, Heike J., et al.
Publicado: (2017)

Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD–ALS spectrum disorders
por: Janssens, Jonathan, et al.
Publicado: (2013)

Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD
por: Wood, Alistair, et al.
Publicado: (2021)

NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility
por: Gleixner, Amanda M., et al.
Publicado: (2022)

Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies
por: del Campo, Marta, et al.
Publicado: (2021)

Synaptic expression of TAR-DNA-binding protein 43 in the mouse spinal cord determined using super-resolution microscopy
por: Broadhead, Matthew J., et al.
Publicado: (2023)

TAR DNA-Binding Protein 43 Is Associated with Rate of Memory, Functional and Global Cognitive Decline in the Decade Prior to Death
por: Buciuc, Marina, et al.
Publicado: (2021)

Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal Ganglia
por: Ohene-Nyako, Michael, et al.
Publicado: (2023)

Towards a TDP-43-Based Biomarker for ALS and FTLD
por: Feneberg, Emily, et al.
Publicado: (2018)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
por: Berning, Britt A., et al.
Publicado: (2019)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
por: Pickles, Sarah, et al.
Publicado: (2022)

HIV-1 Replication in Human Immune Cells Is Independent of TAR DNA Binding Protein 43 (TDP-43) Expression
por: Nehls, Julia, et al.
Publicado: (2014)

Altered localization and functionality of TAR DNA Binding Protein 43 (TDP-43) in niemann- pick disease type C
por: Dardis, A., et al.
Publicado: (2016)

Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS
por: Chang, Cheng-Fu, et al.
Publicado: (2016)

Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
por: Tamaki, Yoshitaka, et al.
Publicado: (2022)

Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U
por: Tsai, Kuen-Jer, et al.
Publicado: (2010)

Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43
por: Tan, Rachel H, et al.
Publicado: (2013)

Nuclear TAR DNA-binding protein 43: A new target for amyotrophic lateral sclerosis treatment
por: Zheng, Mei, et al.
Publicado: (2013)

RNA as a key factor in driving or preventing self-assembly of the TAR DNA-binding protein 43
por: Zacco, Elsa, et al.
Publicado: (2019)

Neurotoxic 43-kDa TAR DNA-binding Protein (TDP-43) Triggers Mitochondrion-dependent Programmed Cell Death in Yeast
por: Braun, Ralf J., et al.
Publicado: (2011)

The N Termini of TAR DNA-Binding Protein 43 (TDP43) C-Terminal Fragments Influence Degradation, Aggregation Propensity, and Morphology
por: Kasu, Yasar Arfat T., et al.
Publicado: (2018)

Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
por: Koga, Shunsuke, et al.
Publicado: (2023)

Phosphorylation regulates proteasomal-mediated degradation and solubility of TAR DNA binding protein-43 C-terminal fragments
por: Zhang, Yong-Jie, et al.
Publicado: (2010)

Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD
por: Yusuff, Tanzeen, et al.
Publicado: (2023)

Aggresome formation and liquid–liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43
por: Watanabe, Seiji, et al.
Publicado: (2020)

Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
por: Koga, Shunsuke, et al.
Publicado: (2023)

The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons()
por: Honda, Daiyu, et al.
Publicado: (2013)

The Role of TAR DNA Binding Protein 43 (TDP-43) as a CandiDate Biomarker of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
por: Gambino, Caterina Maria, et al.
Publicado: (2023)

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes
por: del Campo, Marta, et al.
Publicado: (2018)

Neuronal VCP loss of function recapitulates FTLD-TDP pathology
por: Wani, Abubakar, et al.
Publicado: (2021)

The RNA-Recognition Motifs of TAR DNA-Binding Protein 43 May Play a Role in the Aberrant Self-Assembly of the Protein
por: Zacco, Elsa, et al.
Publicado: (2018)

Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3
por: Xia, Yangliu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u0oos4fr2gsju3u13uju1ogp2i